| __timestamp | Catalyst Pharmaceuticals, Inc. | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 4473654 | 17763000 |
| Thursday, January 1, 2015 | 8597010 | 22180000 |
| Friday, January 1, 2016 | 7910260 | 37257000 |
| Sunday, January 1, 2017 | 7304399 | 27367000 |
| Monday, January 1, 2018 | 15875961 | 64770000 |
| Tuesday, January 1, 2019 | 36881187 | 74986000 |
| Wednesday, January 1, 2020 | 44233754 | 79256000 |
| Friday, January 1, 2021 | 49628000 | 100156000 |
| Saturday, January 1, 2022 | 58183000 | 131408000 |
| Sunday, January 1, 2023 | 133710000 | 152946000 |
Infusing magic into the data realm
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Catalyst Pharmaceuticals, Inc. and Dynavax Technologies Corporation have shown distinct strategies in optimizing these costs. From 2014 to 2023, Catalyst Pharmaceuticals managed to keep their SG&A expenses relatively stable, with a notable increase of around 30% in 2023 compared to 2022. In contrast, Dynavax Technologies saw a more dramatic rise, with expenses nearly doubling over the same period. This suggests a more aggressive expansion or investment strategy. While Catalyst's expenses grew steadily, Dynavax's sharp increase in 2023, reaching approximately 15% higher than Catalyst's, indicates a potential shift in operational focus. Understanding these trends provides valuable insights into each company's strategic priorities and financial management practices.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Catalyst Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Sanofi and Dynavax Technologies Corporation
argenx SE and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Alnylam Pharmaceuticals, Inc. vs Dynavax Technologies Corporation Trends and Insights
Who Optimizes SG&A Costs Better? Intra-Cellular Therapies, Inc. or Catalyst Pharmaceuticals, Inc.
Comparing SG&A Expenses: Dr. Reddy's Laboratories Limited vs Catalyst Pharmaceuticals, Inc. Trends and Insights
Blueprint Medicines Corporation and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Dynavax Technologies Corporation
Verona Pharma plc or Catalyst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? CymaBay Therapeutics, Inc. or Catalyst Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Vericel Corporation and Catalyst Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Protagonist Therapeutics, Inc. vs Dynavax Technologies Corporation